Metraipolis › archive › dc_bf72e3926823
mRNA vaccines for HBV: Mechanisms, preclinical advances, and therapeutic clinical progress — Europe PMC PMID:41583559
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41583559
- DOI
- 10.1016/j.omtn.2025.102819
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T08:22:01.604Z
- SHA-256 of the archived text
196d0dea68107d30aaef8a0426820ea42096b90db66e5ee5fbd2875df3fa8d3b- Stable URL of this page
https://metraipolis.com/documento/dc_bf72e3926823
How to cite
mRNA vaccines for HBV: Mechanisms, preclinical advances, and therapeutic clinical progress — Europe PMC PMID:41583559 — Europe PMC (en), https://europepmc.org/article/MED/41583559 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bf72e3926823 (Metraipolis archive dc_bf72e3926823, sha256 196d0dea68107d30aaef8a0426820ea42096b90db66e5ee5fbd2875df3fa8d3b)
BibTeX
@misc{dcbf72e3926823,
title = {mRNA vaccines for HBV: Mechanisms, preclinical advances, and therapeutic clinical progress — Europe PMC PMID:41583559},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41583559},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bf72e3926823; sha256 196d0dea68107d30aaef8a0426820ea42096b90db66e5ee5fbd2875df3fa8d3b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41583559. Agents can read the archived copy with the MCP tool read_document.